# US 2016/0256687 A1 · Nerve stimulation systems via endovascular leads

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0256687 A1
- Document ID: US20160256687A1
- Status: Published application
- Kind: A1
- Application number: 15/041,150
- Filed: 2016-02-11
- Published: 2016-09-08
- Earliest claimed: 2015-03-03
- Assignees: BIOTRONIK SE & Co. KG
- Applicants: BIOTRONIK SE & Co. KG
- Inventors: Marcelo Baru; Dirk Muessig; Alan Fryer
- Web page: https://patentgrep.com/patent/US20160256687A1

## CPC

- A61B 5/0826: {Detecting or evaluating apnoea events (sleep apnoea A61B5/4818)}
- A61B 5/4836: {Diagnosis combined with treatment in closed-loop systems or methods (A61B5/0036 takes precedence)}
- A61B 5/686: {Permanently implanted devices, e.g. pacemakers, other stimulators, biochips (A61B5/6861 takes precedence)}
- A61N 1/0558: {Anchoring or fixation means therefor}
- A61N 1/056: {Transvascular endocardial electrode systems}
- A61N 1/3601: {of respiratory organs}
- A61N 1/36053: {adapted for vagal stimulation (A61N1/36114 takes precedence)}
- A61N 1/3611: {Respiration control (stimulating respiratory organs A61N1/3601)}
- A61N 1/36114: {Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362)}
- A61N 1/36139: {with automatic adjustment}
- A61N 1/3614: {based on impedance measurement}
- A61N 1/3627: {for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy}
- A61N 1/36514: {controlled by a physiological quantity other than heart potential, e.g. blood pressure (controlled by two or more physical parameters A61N1/36585)}
- A61N 1/37211: {Means for communicating with stimulators}
- A61B 5/0031: {Implanted circuitry}
- A61B 5/086: {by impedance pneumography}
- A61B 5/1116: {Determining posture transitions}
- A61B 2562/0219: Inertial sensors, e.g. accelerometers, gyroscopes, tilt switches
- A61B: DIAGNOSIS; SURGERY; IDENTIFICATION (usefulness limited to only animals A61D)
- A61N: ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY (measurement of bioelectric currents A61B; surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body A61B18/00; anaesthetic apparatus in general A61M; incandescent lamps H01K; infrared radiators for heating H05B)

## Abstract

An implantable stimulation system includes a pulse generator having at least one implantable lead (200) with a proximal end (301) electrically connected to the pulse generator, and a distal end bearing at least one stimulation electrode (201.1, 201.2) electrically connected to the proximal end (301), and thus to the pulse generator. The distal end of the lead (200) includes at least one expandable member (202) configured to laterally extend from the lead (200) in its expanded state, and that carries the stimulation electrode(s) (201.1, 201.2).

## Claims

### Claim 1

An implantable stimulation system including:
a. a pulse generator,
b. an implantable lead (200) extending between:
(1) a proximal end (301) connected to the pulse generator, and
(2) a distal end:
(a) including an expandable member (202) bearing a stimulation electrode (201.1, 201.2) electrically connected to the pulse generator,
(b) wherein the expandable member (202) is configured to expand from:
i. a compact state wherein the expandable member (202) is closely adjacent the lead (200), and
ii. an expanded state wherein the expandable member (202) laterally extends from the lead (200).

### Claim 2 (depends on 1)

The implantable stimulation system of claim 1 wherein the expandable member (202) is formed of elastic insulating material.

### Claim 3 (depends on 1)

The implantable stimulation system of claim 1 wherein the lead (200):
a. extends within a vessel (103.1) having a vessel wall, and
b. through the vessel wall with the expandable member (202) in the expanded state outside the vessel.

### Claim 4 (depends on 3)

The implantable stimulation system of claim 3 wherein the lead further includes a lead electrode (201.3) thereon spaced from the expandable member (202) and situated within the vessel.

### Claim 5 (depends on 1)

The implantable stimulation system of claim 1 wherein the expandable member (202) in the expanded state includes a distally facing front area whereupon the electrode (201.1, 201.2) is situated.

### Claim 6 (depends on 1)

The implantable stimulation system of claim 1 wherein the lead (200) includes a lead electrode (201.3) thereon, with the lead electrode (201.3) being spaced from the distal end of the lead (200) by more than 0.5 cm.

### Claim 7 (depends on 1)

The implantable stimulation system of claim 1 wherein the pulse generator:
a. includes an electrically conductive case (20), and
b. is configured to perform electrical impedance plethysmography via the electrode and the case (20).

### Claim 8 (depends on 1)

The implantable stimulation system of claim 1 wherein the pulse generator includes a kinematic sensor (54) configured to generate a tilt signal indicative of inclination.

### Claim 9 (depends on 1)

The implantable stimulation system of claim 1 wherein the pulse generator:
a. includes a kinematic sensor (54), and
b. is configured to generate a respiration effort signal (REFFS) from an output of the kinematic sensor (54).

### Claim 10 (depends on 1)

The implantable stimulation system of claim 1 wherein the pulse generator:
a. includes an electrically conductive case (20), and
b. is configured to obtain a far-field electrogram via:
(1) at least one of:
(a) the electrode (201.1, 201.2), or
(b) a lead electrode (201.3) spaced from the electrode (201.1, 201.2) on the lead (200), and
(2) the case (20).

### Claim 11 (depends on 10)

The implantable stimulation system of claim 10 wherein the pulse generator is configured to record vascular pressure waveforms depending on the tilt signal and the far field electrogram.

### Claim 12 (depends on 1)

The implantable stimulation system of claim 1 wherein the pulse generator is configured to deliver stimulation pulses for at least one of:
a. vagus nerve stimulation (VNS), and
b. phrenic nerve stimulation (PhrNS), via the electrode (201.1, 201.2).

### Claim 13 (depends on 12)

The implantable stimulation system of claim 12 wherein the pulse generator is configured to:
a. generate a respiration effort signal (REFFS), and
b. deliver VNS and/or PhrNS depending on the REFFS.

### Claim 14 (depends on 1)

The implantable stimulation system of claim 1:
a. further including a cardiac lead (900),
b. wherein the pulse generator (902) is further configured to:
(1) sense cardiac activity, and
(2) deliver cardiac stimulation pulses via the cardiac lead (900).

### Claim 15 (depends on 14)

The implantable stimulation system of claim 14 wherein the pulse generator (902) is configured to:
a. detect at least one of:
(1) atrial fibrillation (AF), and
(2) PR interval,
via the cardiac lead (900), and
b. deliver nerve stimulation pulses via the electrode (201.1, 201.2) in synchrony with cardiac activity.

### Claim 16

An implantable stimulation system including:
a. a pulse generator,
b. an implantable lead (200) extending from the pulse generator:
(1) to an expanded distal end, wherein the expanded distal end:
(a) bears a stimulation electrode (201.1, 201.2) electrically connected to the pulse generator, and
(b) is sized radially greater than the lead (200) extending proximally from the expanded distal end;
(2) within a vessel (103.1) having a vessel wall, with the lead (200) extending through the vessel wall such that its expanded distal end is situated outside the vessel (103.1), whereby the expanded distal end is resistant to withdrawal through the vessel wall.

### Claim 17

A nerve stimulation method using an implantable lead (200) extending between a proximal end (301) connected to a pulse generator and a distal end, the distal end:
A. including an expandable member (202) bearing a stimulation electrode (201.1, 201.2) electrically connected to the pulse generator,
B. wherein the expandable member (202) is configured to expand from:
I. a compact state wherein the expandable member (202) is closely adjacent the lead (200), and
II. an expanded state wherein the expandable member (202) laterally extends from the lead (200),
the method including the steps of:
a. extending the lead (200) within a vessel (103.1) having a vessel wall;
b. extending the distal end through the vessel wall, whereby the expandable member (202) is situated outside the vessel in the expanded state.

### Claim 18 (depends on 17)

The nerve stimulation method of claim 17 wherein:
a. in the expanded state, the expandable member (202) includes a distally facing front area whereupon the electrode (201.1, 201.2) is situated, and
b. when the expandable member (202) is situated outside the vessel in the expanded state, the front area faces the vagus nerve (101.1).

### Claim 19 (depends on 17)

The nerve stimulation method of claim 17 wherein:
a. wherein a cardiac lead (900) extends from the pulse generator,
b. the method further includes the steps of:
(1) sensing cardiac activity via the cardiac lead (900), and
(2) delivering nerve stimulation pulses via the electrode (201.1, 201.2) in synchrony with cardiac activity.

### Claim 20 (depends on 17)

The nerve stimulation method of claim 17 wherein:
a. the lead further includes a lead electrode (201.3) thereon spaced from the expandable member (202) and situated within the vessel,
b. the method further includes the step of measuring impedance between:
(1) the lead electrode (201.3), and
(2) at least one of:
(a) the electrode (201.1, 201.2), and
(b) a case at least partially enclosing the pulse generator.
